Clinical Trials Directory

Trials / Conditions / Neoadjuvant

Neoadjuvant

9 registered clinical trials studyying Neoadjuvant — 7 currently recruiting.

StatusTrialSponsorPhase
RecruitingA Prospective, Multicenter, Phase Ib/II Trial of Ivonescimab (AK112) Combined With Albumin-Paclitaxel and Cisp
NCT07385001
Tang-Du HospitalPhase 1 / Phase 2
RecruitingA Study to Assess Anti-Tumor Activity of Intravenously (IV) Infused Carboplatin With Mirvetuximab Soravtansine
NCT06890338
AbbViePhase 2
RecruitingClinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patien
NCT06479460
The First Affiliated Hospital with Nanjing Medical University—
Active Not RecruitingPembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With
NCT06128863
Maria Sklodowska-Curie National Research Institute of OncologyPhase 2
RecruitingA Study of Neoadjuvant TCHpy（Pyrotinib ，Trastuzumab，Carboplatin and Paclitaxel）for ER+/HER2+ Breast Cancer
NCT06000917
Union Hospital, Tongji Medical College, Huazhong University of Science and TechnologyPhase 2
RecruitingNeoadjuvant of Axitinib Plus PD-1 to Improve Disease Free Survival of Patients With Renal Cell Carcinoma
NCT05738694
ZHOU FANGJIANPhase 3
RecruitingCamrelizumab Plus Apatinib and Temozolomide as Neoadjuvant in High Risk Acral Melanoma
NCT05512481
Peking University Cancer Hospital & InstitutePhase 2
RecruitingProspective Multicenter Clinical Study of Neoadjuvant Imatinib Mesylate for Gastrointestinal Stromal Tumors
NCT04933669
First Affiliated Hospital of Zhejiang UniversityPhase 2
CompletedAn Exploration of Candidates for Neoadjuvant Treatment in Resectable Pancreatic Cancer
NCT06129812
Seoul National University Hospital—